Lunai Bioworks Acquires BBB Delivery Platform for CNS Therapies
Lunai Bioworks, Inc. (NASDAQ: LNAI) today announced it has executed a binding $20 million strategic transaction to acquire blood-brain barrier (BBB) delivery technology and central nervous...